Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis - Image 1

£103.58

CRC Press Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Name: Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
Brand: CRC Press
Price: 103.58 GBP
Availability: InStock

Biomedical Engineering

This is the most expensive it has ever been. Walk away.

£104 today · previous high £104 · all-time low £88

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 619 days • 619 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 619 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £88 (301 days, 48.6%)

Price range: £88 - £104

Price levels: 5 different prices over 619 days

Description

Gleaning information from more than 100 experts in the field of cancer diagnosis, prognosis, and therapy worldwide, Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis determines the significance of clinical validation approaches for several markers. This book examines the use of noninvasive or minimally invasive molecular cancer markers that are under development or currently in use. It deals with a majority of commonly prevalent cancers and can help anyone working in the health-care industry to recommend or develop early diagnostics, at-risk tests, and prognostic biomarkers for various cancers. It explores the practice of determining biomarkers by their characteristics and relative methodologies, and presents the most recent data as well as a number of current and upcoming early diagnostic noninvasive molecular markers for many common cancers. It also considers the sensitivity and specificity of markers, biomarker market, test providers, and patent information. Approximately 30-35 Cancer Specific Noninvasive Molecular Diagnostic Markers in a Single Volume The book details the general and technical aspects of noninvasive cancer markers. It covers imaging, cutting-edge molecular technologies for biomarker development, and noninvasive or minimally invasive sources of molecular markers, as well as quality control and ethical issues in cancer biomarker discovery. It also provides a detailed account of brain, head and neck, and oral cancer markers, and provides information on a number of gastrointestinal cancers, lung cancer, and mesothelioma markers. Emphasizes the Importance of Volatile Markers in Early Cancer Diagnosis Presents noninvasive early molecular markers in urological cancers Describes gynecological and endocrine cancer markers Details noninvasive markers of breast, ovarian, cervical, and thyroid cancers Addresses hematological malignancies Contains information on noninvasive molecular markers in myelodysplastic syndromes, acute myeloid leukemia, Hodgkin’s lymphoma, and multiple myeloma Provides comprehensive information on diagnostic and prognostic biomarkers in cutaneous melanoma This text considers molecular technologies for biomarker development, noninvasive or minimally invasive sources of molecular markers, and quality control and ethical issues in cancer biomarker discovery.

Product Specifications

Brand: CRC Press
Format: paperback
ASIN: 1138076805
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Biomedical Engineering
Domain: Amazon UK
Release Date: 31 March 2017
Listed Since: 04 April 2017

Barcode

No barcode data available

CRC Press Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Humana Tumor Biomarker Discovery: Methods and Protocols 520

Advances in Cancer Biomarkers: From biochemistry to clinic for a critical revision: 867 (Advances in Experimental Medicine and Biology, 867)

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Molecular Biomarkers for Cancer Diagnosis and Therapy

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Encyclopedia of Cancer and Society

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology, 2108)

Environmental Factors, Genes, and the Development of Human Cancers

Abeloff's Clinical Oncology

The Molecular Basis of Cancer

Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6

Cancer Systems and Control for Health Professionals (UICC)

Cancer Biomarkers: Clinical Aspects and Laboratory Determination

Cancer Biomarkers in Diagnosis and Therapeutics

Histological and Serological Tumor Markers and Gene Expression and Their Clinical Usefulness in Cancers

Targeted Therapies in Oncology

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Cancer Biology

Molecular Biology of Human Cancers

Molecular Biology of Human Cancers

Advances in Molecular Pathology, 2018 (Volume 1-1) (Advances, Volume 1-1)

Oxford Textbook of Cancer Biology (Oxford Textbooks in Oncology)